Shilpa Medicare informs about appointment of CEO

19 Sep 2024 Evaluate
Shilpa Medicare has informed about requisite disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 with respect to the appointment of Sridevi Khambhampaty, as Chief Executive Officer (CEO) of Shilpa Biologicals, a wholly owned subsidiary of Shilpa Medicare. (Annexure A).

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

865.60 18.25 (2.15%)
20-Sep-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1863.60
Dr. Reddys Lab 6552.50
Cipla 1639.50
Lupin 2152.15
Zydus Lifesciences 1055.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.